RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis AI Analysis of ADMA
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

ADMA Biologics Inc stock downgraded from Sell Candidate to Strong Sell Candidate after Monday trading session
(Updated on Oct 14, 2024)

Sell candidate since Oct 10, 2024 Loss -3.76%

The ADMA Biologics Inc stock price fell by -4.52% on the last day (Monday, 14th Oct 2024) from $17.15 to $16.37. During the last trading day the stock fluctuated 6.65% from a day low at $16.08 to a day high of $17.15. The price has fallen in 6 of the last 10 days and is down by -18.11% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -3 million shares and in total, 6 million shares were bought and sold for approximately $100.67 million.

Given the current short-term trend, the stock is expected to rise 58.67% during the next 3 months and, with a 90% probability hold a price between $25.97 and $33.65 at the end of this 3-month period.

ADMA Signals & Forecast

There are few to no technical positive signals at the moment. The ADMA Biologics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $18.86 and $18.45. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, October 08, 2024, and so far it has fallen -20.99%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for ADMA Biologics Inc stock

ADMA Biologics Inc finds support from accumulated volume at $15.96 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.07 between high and low, or 6.65%. For the last week, the stock has had daily average volatility of 9.77%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ADMA) For The Upcoming Trading Day Of Tuesday 15th

For the upcoming trading day on Tuesday, 15th we expect ADMA Biologics Inc to open at $16.53, and during the day (based on 14 day Average True Range), to move between $15.29 and $17.45, which gives a possible trading interval of +/-$1.08 (+/-6.61%) up or down from last closing price. If ADMA Biologics Inc takes out the full calculated possible swing range there will be an estimated 13.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $15.96 (2.50%) than the resistance at $17.01 (3.91%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ADMA Biologics Inc stock A Buy?

The ADMA Biologics Inc stock holds several negative signals and despite the positive trend, we believe ADMA Biologics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.750 Strong Sell Candidate Downgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on October 15, 2024 - $16.53 ( 1.00%). The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ADMA

Fibonacci Support & Resistance Levels

Level Price
R3 17.60 7.53%
R2 17.19 5.04%
R1 16.94 3.49%
Price 16.37
S1 16.12 -1.50%
S2 15.87 -3.04%
S3 15.46 -5.54%

Accumulated Volume Support & Resistance Levels

Level Price
R3 19.98 22.05%
R2 18.38 12.28%
R1 17.01 3.91%
Price 16.37
S1 15.96 -2.50%
S2 13.75 -16.00%
S3 12.36 -24.50%

FAQ

What is the symbol for ADMA Biologics Inc Stock and on which exchange is it traded?
The symbol for ADMA Biologics Inc is ADMA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ADMA Biologics Inc Stock?
The ADMA Biologics Inc stock holds several negative signals and despite the positive trend, we believe ADMA Biologics Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy ADMA Biologics Inc Stock?
ADMA Biologics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ADMA Biologics Inc Stock.

What's the current price of ADMA Biologics Inc Stock?
As of the end of day on the Oct 14, 2024, the price of an ADMA Biologics Inc (ADMA) share was $16.37.

What is the 52-week high and low for ADMA Biologics Inc Stock?
The 52-week high for ADMA Biologics Inc Stock is $21.13 and the 52-week low is $3.06.

What is the market capitalization of ADMA Biologics Inc Stock?
As of the Oct 14, 2024, the market capitalization of ADMA Biologics Inc is 3.996B.

When is the next earnings date for ADMA Biologics Inc?
The upcoming earnings date for ADMA Biologics Inc is Nov 13, 2024.
Click to get the best stock tips daily for free!
ABOUT ADMA BIOLOGICS INC
ADMA Biologics
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the ...
GOLDEN STAR
Ticker Change Signal Date
SUN
$53.12
1.20% Oct 09
BRK-B
$455.90
0.95% Oct 09
ESGR
$321.00
0.732% Oct 09
WTRG
$38.60
1.45% Oct 09
VNT
$33.53
2.92% Oct 09

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE